ConductScience.org, home

Paper195091

Presence of Epstein-Barr virus receptors, but absence of virus penetration, in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt 4).

Menezes J and 4 others. J Virol, 1977. Cited by 79 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Presence of Epstein-Barr virus receptors, but absence of virus penetration, in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt 4). Papers, record 195091. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/195091

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Presence of Epstein-Barr virus receptors, but absence of virus penetration, in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt 4).
PubMed
Journal
J Virol
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
79
iCite
Relative citation ratio, by iCite
1.74
iCite
Revised in PubMed
2020-07-24
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Menezes JJ
2Seigneurin JMJ M
3Patel PP
4Bourkas AA
5Lenoir GG

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Binding SitesMajor topic
Herpesvirus 4, HumanMajor topic
Adsorption
Burkitt Lymphoma
Cell Line
Cell Membrane
Fluorescent Antibody Technique
T-Lymphocytes
Virus Replication

Source PubMed

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,278,051CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.Cancer1965https://conductscience.org/library/papers/14278051PubMed
214,304,234A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.J Clin Pathol1965https://conductscience.org/library/papers/14304234PubMed
3163,715Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoic cell lines and in the blood of patients with infectious mononucleosis.Clin Immunol Immunopathol1975https://conductscience.org/library/papers/163715PubMed
4165,958Biological differences between Epstein-Barr virus (EBV) strains with regard to lymphocyte transforming ability, superinfection and antigen induction.Exp Cell Res1975https://conductscience.org/library/papers/165958PubMed
5176,601Effect of interferon on lymphocyte transformation and nuclear antigen production by Epstein-Barr virus.Nature1976https://conductscience.org/library/papers/176601PubMed
6177,360Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation.Infect Immun1976https://conductscience.org/library/papers/177360PubMed
7179,629Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.Biomedicine1975https://conductscience.org/library/papers/179629PubMed
84,133,943Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.Int J Cancer1973https://conductscience.org/library/papers/4133943PubMed
94,136,723Establishment and characteristics of two unique cell lines from patients with lymphosarcoma.Int J Cancer1974https://conductscience.org/library/papers/4136723PubMed
104,163,469Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long-term cultures.Proc Soc Exp Biol Med1967https://conductscience.org/library/papers/4163469PubMed
114,346,033Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.Proc Natl Acad Sci U S A1973https://conductscience.org/library/papers/4346033PubMed
124,357,682Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes.J Exp Med1973https://conductscience.org/library/papers/4357682PubMed
134,547,172Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia.J Natl Cancer Inst1974https://conductscience.org/library/papers/4547172PubMed
144,567,231Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.J Natl Cancer Inst1972https://conductscience.org/library/papers/4567231PubMed
1559,946Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells.Scand J Immunol1976https://conductscience.org/library/papers/59946PubMed

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.

PMIDTitleJournalYearIn PapersSource
32,238,579CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells.J Virol2020https://conductscience.org/library/papers/32238579PubMed
16,606,841Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16606841PubMed
12,409,611Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/12409611PubMed
11,044,119CD21-mediated entry and stable infection by Epstein-Barr virus in canine and rat cells.J Virol2000https://conductscience.org/library/papers/11044119PubMed
9,151,859Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.J Virol1997https://conductscience.org/library/papers/9151859PubMed
7,913,508Determination of the role for CD21 during Epstein-Barr virus infection of B-lymphoblastoid cells.J Virol1994https://conductscience.org/library/papers/7913508PubMed
7,745,743Isolation of Epstein-Barr virus-infected clones of the human T-cell line MT-2: use of recombinant viruses with a positive selection marker.J Virol1995https://conductscience.org/library/papers/7745743PubMed
7,621,403Virus receptors: implications for pathogenesis and the design of antiviral agents.Clin Microbiol Rev1995https://conductscience.org/library/papers/7621403PubMed
6,298,467Sendai virus envelopes can mediate Epstein-Barr virus binding to and penetration into Epstein-Barr virus receptor-negative cells.J Virol1983https://conductscience.org/library/papers/6298467PubMed
6,283,164Epstein-Barr virus-lymphoid cell interactions. III. Effect of concanavalin A and saccharides on Epstein-Barr virus penetration.J Virol1982https://conductscience.org/library/papers/6283164PubMed
6,281,475Use of fluoresceinated Epstein-Barr virus to study Epstein-Barr virus-lymphoid cell interactions.J Virol1982https://conductscience.org/library/papers/6281475PubMed
6,254,082Transfer of Epstein-Barr virus receptors to receptor-negative cells permits virus penetration and antigen expression.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6254082PubMed
6,196,189Cytoplasmic RNA from normal and malignant human cells shows homology to the DNAs of Epstein-Barr virus and human adenoviruses.EMBO J1983https://conductscience.org/library/papers/6196189PubMed
2,836,619A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein-Barr virus.J Virol1988https://conductscience.org/library/papers/2836619PubMed
2,831,405Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21).J Virol1988https://conductscience.org/library/papers/2831405PubMed
2,555,536Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells.J Virol1989https://conductscience.org/library/papers/2555536PubMed
1,851,872Expression of a human cytomegalovirus receptor correlates with infectibility of cells.J Virol1991https://conductscience.org/library/papers/1851872PubMed
1,706,754Infection of human thymocytes by Epstein-Barr virus.J Exp Med1991https://conductscience.org/library/papers/1706754PubMed
1,664,981Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.Springer Semin Immunopathol1991https://conductscience.org/library/papers/1664981PubMed
1,424,280T lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE).Clin Exp Immunol1992https://conductscience.org/library/papers/1424280PubMed

See all 23 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CR21,380PubTator's text mininghttps://conductscience.org/library/genes/1380

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/195091

GET https://conductscience.org/api/papers/v1/195091/cited_by?page=2